Category: Miscellaneous

The Most Popular Cannabis Concentrate Strains of 2025

A surge in live resin, rosin and solventless options has shaped concentrate trends in 2025, with consumers gravitating toward cultivars that deliver terpene-rich flavor and strong, reliable effects. Dispensary data across legal markets shows a clear preference for certain strains, especially those known for pungent profiles, high THC output and consistency from batch to batch. …

Continue reading

The 50 Most Popular Cannabis Strains of 2025 (U.S. Edition)

In 2025, the U.S. legal-market cannabis scene continued to shift, as new strains, revived classics and consumer favorites all compete on dispensary shelves. Based on an analysis of cannabis sales data across legal cannabis states, as well as cannabis review sites like Leafly, below are the 50 most popular cannabis strains throughout 2025. Blue Dream …

Continue reading

Legal Status of Hemp-Derived THC Products in All 50 States (November 2025)

As of November 2025, the legal status of hemp-derived THC products (including Delta-8 THC, Delta-10 THC, THCA, and other similar cannabinoids) varies widely by state. Below is a state-by-state overview, indicating whether these products are fully allowed, regulated with restrictions, or banned. It’s worth noting that legislation was approved recently at the federal level that …

Continue reading

The Best Cannabis Strains for Christmas (2025 Edition)

By John Carmichael As we ease into the holiday season and Christmas nears, the right strain can make things a little brighter and a lot more relaxed. For this 2025 Christmas guide, we pulled together a dozen strains with winter-ready names, seasonal flavors and proven popularity on modern menus across the country. Peppermint Kush Peppermint …

Continue reading

MJBowl Announces 2025 MVPs Across California and New York

The 2025 MJBowl has announced its full slate of first-place MVPs across California and New York, wrapping weeks of judging that highlighted the most impressive flower, pre-rolls, vapes, concentrates and edibles on both coasts. This year’s list reflects a mix of veteran producers, rising small-batch brands and an especially strong showing from solventless entries.

Continue reading

The U.S. Supreme Court Could Soon End Federal Cannabis Prohibition: Here’s Why It’s No Longer a Far-Fetched Possibility

Growing legal and political developments are raising new questions about whether the U.S. Supreme Court could soon revisit and potentially strike down the federal prohibition on marijuana. With most states now operating their own medical or adult-use marijuana systems, the legal landscape has become far more complex than it was when federal prohibition was last …

Continue reading

Avicanna’s New Oral Delivery Platform Boosts Cannabinoid Absorption in Preclinical Testing

Avicanna Inc. says new preclinical research find that its latest oral drug delivery platform could significantly improve how the body absorbs cannabinoids, and the company has moved to protect the technology with a provisional patent filing in the United States. The Toronto-based biopharmaceutical company announced that its Powder Drug Delivery System, branded as PwdRx, delivered …

Continue reading

420 Peer-Reviewed Cannabis Studies, All Published in 2025

Scientific interest in cannabis has accelerated at an unprecedented pace, with 2025 producing more peer-reviewed research than any year on record. Across oncology, neurology, psychiatry, pain, metabolism, immunology, addiction, agriculture and more, researchers published over 420 new studies examining the plant’s therapeutic potential, safety profile, cultivation techniques, and real-world impacts of both the plant and …

Continue reading

Report: Cannabis Vaporizer Market Valued at $6.6 Billion, to Grow to $17 Billion by 2032

The cannabis vaporizer market is on track for massive expansion over the next decade, driven by rapid legalization, shifting consumer habits, and a wave of device innovation. A new industry report projects the global vape sector to grow from $5.06 billion in 2023 and $6.6 billion in 2025, to $17.11 billion by 2032, a sharp …

Continue reading

Breaking New Ground: IGC-AD1 Targets Agitation in Alzheimer’s With a Cannabis-Based Investigational Therapy

IGC Pharma is advancing a new approach to one of the most difficult and exhausting symptoms of Alzheimer’s disease: agitation. The company’s investigational therapy, IGC-AD1, is now in a Phase 2 clinical study known as the CALMA trial, and early data show meaningful reductions in agitation along with signals that may point to potential cognitive …

Continue reading